| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: Q4QED3
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006082 | organic acid metabolic process | 3 | 2 |
| GO:0006629 | lipid metabolic process | 3 | 2 |
| GO:0006631 | fatty acid metabolic process | 4 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
| GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
| GO:0043436 | oxoacid metabolic process | 4 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0044255 | cellular lipid metabolic process | 3 | 2 |
| GO:0044281 | small molecule metabolic process | 2 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000062 | fatty-acyl-CoA binding | 4 | 7 |
| GO:0000166 | nucleotide binding | 3 | 7 |
| GO:0005488 | binding | 1 | 7 |
| GO:0008289 | lipid binding | 2 | 7 |
| GO:0017076 | purine nucleotide binding | 4 | 7 |
| GO:0030554 | adenyl nucleotide binding | 5 | 7 |
| GO:0032553 | ribonucleotide binding | 3 | 7 |
| GO:0032555 | purine ribonucleotide binding | 4 | 7 |
| GO:0032559 | adenyl ribonucleotide binding | 5 | 7 |
| GO:0033218 | amide binding | 2 | 7 |
| GO:0036094 | small molecule binding | 2 | 7 |
| GO:0097159 | organic cyclic compound binding | 2 | 7 |
| GO:0097367 | carbohydrate derivative binding | 2 | 7 |
| GO:0120227 | acyl-CoA binding | 3 | 7 |
| GO:1901265 | nucleoside phosphate binding | 3 | 7 |
| GO:1901363 | heterocyclic compound binding | 2 | 7 |
| GO:1901567 | fatty acid derivative binding | 3 | 7 |
| GO:1901681 | sulfur compound binding | 2 | 7 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 288 | 292 | PF00656 | 0.542 |
| CLV_C14_Caspase3-7 | 41 | 45 | PF00656 | 0.365 |
| CLV_NRD_NRD_1 | 100 | 102 | PF00675 | 0.324 |
| CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.416 |
| CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.595 |
| CLV_NRD_NRD_1 | 337 | 339 | PF00675 | 0.608 |
| CLV_NRD_NRD_1 | 381 | 383 | PF00675 | 0.590 |
| CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.421 |
| CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.552 |
| CLV_PCSK_FUR_1 | 326 | 330 | PF00082 | 0.609 |
| CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.324 |
| CLV_PCSK_KEX2_1 | 267 | 269 | PF00082 | 0.608 |
| CLV_PCSK_KEX2_1 | 328 | 330 | PF00082 | 0.524 |
| CLV_PCSK_KEX2_1 | 336 | 338 | PF00082 | 0.393 |
| CLV_PCSK_KEX2_1 | 381 | 383 | PF00082 | 0.590 |
| CLV_PCSK_KEX2_1 | 493 | 495 | PF00082 | 0.609 |
| CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.561 |
| CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.324 |
| CLV_PCSK_PC1ET2_1 | 267 | 269 | PF00082 | 0.608 |
| CLV_PCSK_PC1ET2_1 | 328 | 330 | PF00082 | 0.527 |
| CLV_PCSK_PC1ET2_1 | 336 | 338 | PF00082 | 0.393 |
| CLV_PCSK_PC1ET2_1 | 493 | 495 | PF00082 | 0.605 |
| CLV_PCSK_SKI1_1 | 104 | 108 | PF00082 | 0.421 |
| CLV_PCSK_SKI1_1 | 173 | 177 | PF00082 | 0.303 |
| CLV_PCSK_SKI1_1 | 231 | 235 | PF00082 | 0.409 |
| CLV_PCSK_SKI1_1 | 263 | 267 | PF00082 | 0.576 |
| CLV_PCSK_SKI1_1 | 474 | 478 | PF00082 | 0.695 |
| CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.324 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.657 |
| DEG_SPOP_SBC_1 | 431 | 435 | PF00917 | 0.639 |
| DOC_CKS1_1 | 184 | 189 | PF01111 | 0.421 |
| DOC_PP1_RVXF_1 | 61 | 67 | PF00149 | 0.354 |
| DOC_PP4_FxxP_1 | 29 | 32 | PF00568 | 0.521 |
| DOC_PP4_FxxP_1 | 353 | 356 | PF00568 | 0.544 |
| DOC_USP7_MATH_1 | 358 | 362 | PF00917 | 0.571 |
| DOC_USP7_MATH_1 | 449 | 453 | PF00917 | 0.753 |
| DOC_USP7_MATH_1 | 456 | 460 | PF00917 | 0.678 |
| DOC_USP7_MATH_1 | 476 | 480 | PF00917 | 0.579 |
| DOC_USP7_UBL2_3 | 231 | 235 | PF12436 | 0.506 |
| DOC_USP7_UBL2_3 | 263 | 267 | PF12436 | 0.672 |
| DOC_USP7_UBL2_3 | 328 | 332 | PF12436 | 0.593 |
| DOC_USP7_UBL2_3 | 470 | 474 | PF12436 | 0.683 |
| DOC_USP7_UBL2_3 | 483 | 487 | PF12436 | 0.628 |
| DOC_WW_Pin1_4 | 183 | 188 | PF00397 | 0.421 |
| DOC_WW_Pin1_4 | 432 | 437 | PF00397 | 0.672 |
| LIG_14-3-3_CanoR_1 | 124 | 130 | PF00244 | 0.565 |
| LIG_14-3-3_CanoR_1 | 302 | 306 | PF00244 | 0.498 |
| LIG_BIR_III_4 | 291 | 295 | PF00653 | 0.548 |
| LIG_BRCT_BRCA1_1 | 21 | 25 | PF00533 | 0.569 |
| LIG_deltaCOP1_diTrp_1 | 137 | 143 | PF00928 | 0.451 |
| LIG_deltaCOP1_diTrp_1 | 90 | 95 | PF00928 | 0.324 |
| LIG_FHA_1 | 114 | 120 | PF00498 | 0.253 |
| LIG_FHA_1 | 50 | 56 | PF00498 | 0.253 |
| LIG_FHA_2 | 267 | 273 | PF00498 | 0.585 |
| LIG_FHA_2 | 283 | 289 | PF00498 | 0.429 |
| LIG_FHA_2 | 307 | 313 | PF00498 | 0.549 |
| LIG_FHA_2 | 317 | 323 | PF00498 | 0.460 |
| LIG_FHA_2 | 363 | 369 | PF00498 | 0.721 |
| LIG_FHA_2 | 386 | 392 | PF00498 | 0.606 |
| LIG_FHA_2 | 72 | 78 | PF00498 | 0.354 |
| LIG_LIR_Apic_2 | 128 | 134 | PF02991 | 0.599 |
| LIG_LIR_Apic_2 | 28 | 32 | PF02991 | 0.523 |
| LIG_LIR_Gen_1 | 113 | 123 | PF02991 | 0.324 |
| LIG_LIR_Gen_1 | 137 | 147 | PF02991 | 0.438 |
| LIG_LIR_Gen_1 | 212 | 220 | PF02991 | 0.324 |
| LIG_LIR_Nem_3 | 11 | 17 | PF02991 | 0.621 |
| LIG_LIR_Nem_3 | 113 | 118 | PF02991 | 0.324 |
| LIG_LIR_Nem_3 | 137 | 143 | PF02991 | 0.451 |
| LIG_LIR_Nem_3 | 191 | 197 | PF02991 | 0.331 |
| LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.421 |
| LIG_LIR_Nem_3 | 90 | 94 | PF02991 | 0.324 |
| LIG_MAD2 | 453 | 461 | PF02301 | 0.631 |
| LIG_Pex14_1 | 140 | 144 | PF04695 | 0.349 |
| LIG_Pex14_2 | 25 | 29 | PF04695 | 0.528 |
| LIG_Pex14_2 | 66 | 70 | PF04695 | 0.421 |
| LIG_REV1ctd_RIR_1 | 3 | 11 | PF16727 | 0.540 |
| LIG_SH2_CRK | 144 | 148 | PF00017 | 0.336 |
| LIG_SH2_NCK_1 | 36 | 40 | PF00017 | 0.421 |
| LIG_SH2_STAP1 | 115 | 119 | PF00017 | 0.253 |
| LIG_SH2_STAP1 | 211 | 215 | PF00017 | 0.324 |
| LIG_SH2_STAP1 | 36 | 40 | PF00017 | 0.421 |
| LIG_SH2_STAT5 | 115 | 118 | PF00017 | 0.354 |
| LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.303 |
| LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.324 |
| LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.469 |
| LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.354 |
| LIG_SH3_3 | 14 | 20 | PF00018 | 0.550 |
| LIG_SH3_3 | 240 | 246 | PF00018 | 0.472 |
| LIG_SH3_3 | 29 | 35 | PF00018 | 0.665 |
| LIG_SH3_3 | 79 | 85 | PF00018 | 0.328 |
| LIG_TRAF2_1 | 285 | 288 | PF00917 | 0.618 |
| LIG_TRAF2_1 | 319 | 322 | PF00917 | 0.553 |
| LIG_TRAF2_1 | 39 | 42 | PF00917 | 0.365 |
| LIG_UBA3_1 | 118 | 125 | PF00899 | 0.409 |
| LIG_UBA3_1 | 149 | 155 | PF00899 | 0.421 |
| LIG_WRC_WIRS_1 | 2 | 7 | PF05994 | 0.530 |
| LIG_WRC_WIRS_1 | 305 | 310 | PF05994 | 0.592 |
| MOD_CK1_1 | 199 | 205 | PF00069 | 0.337 |
| MOD_CK1_1 | 261 | 267 | PF00069 | 0.670 |
| MOD_CK2_1 | 282 | 288 | PF00069 | 0.661 |
| MOD_CK2_1 | 295 | 301 | PF00069 | 0.395 |
| MOD_CK2_1 | 306 | 312 | PF00069 | 0.506 |
| MOD_CK2_1 | 316 | 322 | PF00069 | 0.461 |
| MOD_CK2_1 | 362 | 368 | PF00069 | 0.728 |
| MOD_CK2_1 | 405 | 411 | PF00069 | 0.752 |
| MOD_CK2_1 | 454 | 460 | PF00069 | 0.676 |
| MOD_Cter_Amidation | 324 | 327 | PF01082 | 0.542 |
| MOD_Cter_Amidation | 491 | 494 | PF01082 | 0.557 |
| MOD_Cter_Amidation | 6 | 9 | PF01082 | 0.641 |
| MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.583 |
| MOD_GlcNHglycan | 235 | 238 | PF01048 | 0.453 |
| MOD_GlcNHglycan | 260 | 263 | PF01048 | 0.576 |
| MOD_GlcNHglycan | 418 | 421 | PF01048 | 0.811 |
| MOD_GlcNHglycan | 444 | 447 | PF01048 | 0.655 |
| MOD_GSK3_1 | 257 | 264 | PF00069 | 0.666 |
| MOD_GSK3_1 | 358 | 365 | PF00069 | 0.676 |
| MOD_GSK3_1 | 427 | 434 | PF00069 | 0.681 |
| MOD_N-GLC_1 | 178 | 183 | PF02516 | 0.337 |
| MOD_N-GLC_2 | 397 | 399 | PF02516 | 0.654 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.517 |
| MOD_NEK2_1 | 398 | 403 | PF00069 | 0.561 |
| MOD_NEK2_1 | 442 | 447 | PF00069 | 0.650 |
| MOD_PKA_1 | 266 | 272 | PF00069 | 0.585 |
| MOD_PKA_2 | 199 | 205 | PF00069 | 0.356 |
| MOD_PKA_2 | 301 | 307 | PF00069 | 0.498 |
| MOD_Plk_1 | 362 | 368 | PF00069 | 0.689 |
| MOD_Plk_2-3 | 405 | 411 | PF00069 | 0.543 |
| MOD_Plk_4 | 1 | 7 | PF00069 | 0.517 |
| MOD_Plk_4 | 125 | 131 | PF00069 | 0.608 |
| MOD_Plk_4 | 19 | 25 | PF00069 | 0.454 |
| MOD_Plk_4 | 295 | 301 | PF00069 | 0.582 |
| MOD_Plk_4 | 65 | 71 | PF00069 | 0.354 |
| MOD_Plk_4 | 83 | 89 | PF00069 | 0.354 |
| MOD_ProDKin_1 | 183 | 189 | PF00069 | 0.421 |
| MOD_ProDKin_1 | 432 | 438 | PF00069 | 0.669 |
| MOD_SUMO_for_1 | 356 | 359 | PF00179 | 0.647 |
| MOD_SUMO_for_1 | 463 | 466 | PF00179 | 0.644 |
| MOD_SUMO_rev_2 | 11 | 17 | PF00179 | 0.594 |
| MOD_SUMO_rev_2 | 75 | 85 | PF00179 | 0.361 |
| TRG_ENDOCYTIC_2 | 115 | 118 | PF00928 | 0.354 |
| TRG_ENDOCYTIC_2 | 144 | 147 | PF00928 | 0.331 |
| TRG_ENDOCYTIC_2 | 194 | 197 | PF00928 | 0.324 |
| TRG_ENDOCYTIC_2 | 67 | 70 | PF00928 | 0.403 |
| TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.421 |
| TRG_ER_diArg_1 | 197 | 200 | PF00400 | 0.324 |
| TRG_ER_diArg_1 | 381 | 383 | PF00400 | 0.590 |
| TRG_NES_CRM1_1 | 288 | 301 | PF08389 | 0.537 |
| TRG_NLS_Bipartite_1 | 326 | 340 | PF00514 | 0.531 |
| TRG_NLS_MonoExtN_4 | 490 | 497 | PF00514 | 0.578 |
| TRG_Pf-PMV_PEXEL_1 | 112 | 117 | PF00026 | 0.396 |
| TRG_Pf-PMV_PEXEL_1 | 381 | 386 | PF00026 | 0.696 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5F7 | Leptomonas seymouri | 47% | 100% |
| A0A3Q8IDY9 | Leishmania donovani | 91% | 100% |
| A4H904 | Leishmania braziliensis | 70% | 100% |
| A4HXD5 | Leishmania infantum | 91% | 100% |
| E9AR30 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |